文献速递骨肌胸部CT

椎体骨折风险评估:胸部能谱CT测量的椎体骨小梁衰减值与羟基磷灰石浓度的对比研究

Risk of vertebral fractures: evaluation on vertebral trabecular attenuation value and hydroxyapatite concentration in patients by chest spectral CT.
PubMed 文献 · Br J Radiol · 2021-01-19

回顾性分析216例胸部CT患者的T11-L1椎体,比较能谱CT测量的羟基磷灰石浓度与传统CT测量的骨小梁衰减值对椎体骨折的鉴别效能。男性羟基磷灰石浓度AUC为0.916,女性为0.870,均高于传统CT衰减值(男性p=0.007,女性p=0.005)。能谱CT定量评估可能较传统CT具有更高准确性。

要点

  • 能谱CT测量的椎体羟基磷灰石浓度鉴别椎体骨折的AUC男性0.916、女性0.870。
  • 男性最佳阈值72.27 mg/cm3,女性最佳阈值74.79 mg/cm3。
  • 能谱CT与常规CT的AUC差异有统计学意义(男性p=0.007,女性p=0.005)。

核心结论

  • 能谱CT定量评估可能较传统CT具有更高准确性来分析椎体骨折风险。
  • 胸部能谱CT测量的羟基磷灰石浓度可能用于评估骨折风险。

研究设计与样本

  • 回顾性研究,纳入216例患者,分析胸部CT扫描的T11-L1椎体。
  • 采用能谱成像测量椎体羟基磷灰石浓度,传统CT测量骨小梁衰减值,以有无椎体骨折分组。

关键影像表现/征象

  • 能谱CT测量椎体羟基磷灰石浓度,传统CT测量骨小梁衰减值,用于区分有无椎体骨折。

诊断标准与关键数值

  • 男性:羟基磷灰石浓度AUC 0.916,最佳阈值72.27 mg/cm3,特异度91.7%、敏感度80.2%、NPV 36.7%、PPV 98.7%。
  • 女性:羟基磷灰石浓度AUC 0.870,最佳阈值74.79 mg/cm3,特异度100.0%、敏感度77.8%、NPV 47.4%、PPV 100.0%。
  • 能谱CT羟基磷灰石浓度与传统CT衰减值鉴别椎体骨折的AUC差异有统计学意义(男性p=0.007,女性p=0.005)。

临床应用与阅片要点

  • 胸部能谱CT测量的羟基磷灰石浓度可能用于评估椎体骨折风险。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To analyze vertebral fractures risk in patients with chest scans by evaluating vertebral hydroxyapatite concentration measured on spectral CT compared to trabecular attenuation value measured on conventional CT.

METHODS: Our retrospective study reviewed CT of 216 patients. Analysis of vertebral (T11 - L1) hydroxyapatite concentration by spectral imaging and trabecular attenuation value by conventional CT imaging were performed in patients with chest CT examinations. Specificity, sensitivity, negative predictive value (NPV), and positive predictive value (PPV) were performed by using receiver operating characteristic (ROC) curves in patients with and without vertebral fractures.

RESULTS: In male patients, vertebral hydroxyapatite concentration had high area under the ROC curve (0.916), by using the optimal threshold of 72.27 mg/cm3, specificity, sensitivity, NPV, and PPV were 91.7, 80.2, 36.7, and 98.7%, respectively. In female patients, vertebral hydroxyapatite concentration also had high area under the ROC curve (0.870), by using the optimal threshold of 74.79 mg/cm3, specificity, sensitivity, NPV, and PPV were 100.0, 77.8, 47.4, and 100.0%, respectively. Area under the ROC curve was significantly different between spectral CT-measured bone hydroxyapatite concentration and conventional CT-measured attenuation value in distinguishing vertebral fractures (p = 0.007 for males; p = 0.005 for females).

CONCLUSIONS: Quantitative assessment with spectral CT may appear as higher accuracy than that of conventional CT imaging to analyze risk of vertebral fractures. Hydroxyapatite concentration measured with chest spectral CT may be used to evaluate risk of bone fractures.

ADVANCES IN KNOWLEDGE: Hydroxyapatite concentration measured with chest spectral CT may be used to evaluate risk of bone fractures.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Ma Q, Hou X, Cheng X, et al. Risk of vertebral fractures: evaluation on vertebral trabecular attenuation value and hydroxyapatite concentration in patients by chest spectral CT. Br J Radiol. 2021. PMID: 33417486. doi:10.1259/bjr.20200234

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。